Large study finds greater risk of Infection with progressive forms than RRMS
by Patricia Valerio, PhD | October 20, 2022 People with progressive forms of multiple sclerosis (MS) are nearly four times more likely…
Survival Much Higher for MS Patients Who Take DMTs as Directed: Study
Medication adherence linked to greater survival for US veterans prescribed DMTs by Marisa Wexler, MS | September 23, 2022 The likelihood of survival…
Stuart Schlossman
Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies
ORIGINAL RESEARCH article – Front. Immunol., 05 August 2022 https://doi.org/10.3389/fimmu.2022.926318 — Sec. Vaccines and Molecular Therapeutics – —————————————– https://www.frontiersin.org/journals/immunology…
Stuart Schlossman
Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability
Abstract Objective: We sought to characterize spinal cord atrophy along the entire spinal cord in the major multiple sclerosis (MS) phenotypes,…
Stuart Schlossman
Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: A population-based case-control study
Elia Sechi 1, Steven Messina 2, B Mark Keegan 1, Marina Buciuc 1, Sean J Pittock 3, Orhun H Kantarci…
Stuart Schlossman
Video: Learning about The CASA-MS study, a Comprehensive Assessment of Severely Affected Multiple Sclerosis
Click to Subscribe for the MS Beacon eNewsletter and MS educational events Visit our MS Learning Channel on YouTube:…
Stuart Schlossman
Rituximab Outperforms Tecfidera at Preventing Relapses in Phase 3 Trial
by Marisa Wexler, MS | July 15, 2022 Patients on rituximab MS treatment 5 times less likely to experience relapse…
Stuart Schlossman
EDSS ‘0’ is not normal: Multiple sclerosis disease burden below the clinical threshold
2022 Jul 13;13524585221108297 – doi: 10.1177/13524585221108297. Online ahead of print. Stephen C Krieger 1, Ali Antoine 1, James F Sumowski 1 PMID: 35832024 DOI: 10.1177/13524585221108297 #MS disability…
Stuart Schlossman
Health Care Utilization, Prodromal Symptoms Prior to Pediatric-Onset MS
By Sheila Jacobs – June 7, 2022 Neurologic complaints included headache, sensory symptoms, visual symptoms, and motor symptoms in the 2…
Stuart Schlossman
Diroximel Fumarate for Relapsing MS: How Does It Affect Clinical Outcomes?
June 8, 2022 – Mary Stroka The most frequent AEs were flushing (32.3%), nasopharyngitis (24.6%), and MS relapse during treatment with…
Stuart Schlossman
